Healthcare Triangle (HCTI) vote: board elected, SRCO ratified

Rhea-AI Filing Summary

Healthcare Triangle, Inc. reported results of its November 7, 2025 annual meeting. Shareholders elected four directors for one-year terms and ratified SRCO Professional Corporation as independent auditor for 2025.

Participation was strong: 21,423,722 shares (approximately 82.80% of 25,873,304 entitled shares) were represented, including common stock and Series A Super Voting Preferred Stock.

Director votes: Sujatha Ramesh For 20,253,344, Withheld 7,524; Dave Rosa For 20,171,021, Withheld 89,847; Jainal Bhuiyan For 20,244,585, Withheld 16,283; Ron McClurg For 20,250,055, Withheld 10,813. Each director vote recorded 1,162,854 broker non-votes.

Auditor ratification: For 21,275,588, Against 57,036, Abstain 91,098, with 0 broker non-votes.

false 0001839285 0001839285 2025-11-07 2025-11-07 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

Form 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934

Date of Report (Date of earliest event reported) November 7, 2025

HEALTHCARE TRIANGLE, INC.

(Exact name of registrant as specified in its charter)

Delaware		001-40903		84-3559776
(State or other jurisdiction of incorporation)		(Commission File Number)		(IRS Employer Identification No.)

7901 Stoneridge Dr., Suite 220 Pleasanton, CA 94588

(Address of principal executive offices)

(925)-270-4812

(Registrant’s telephone number, including area code)

N/A

(Former name or former address, if changed since last report.)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class		Trading Symbol(s)		Name of each exchange on which registered
Common Stock, par value $0.00001 per share		HCTI		The Nasdaq Stock Market LLC

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☒

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 5.07. Submission of Matters to a Vote of Security Holders.

On November 7, 2025, at the virtual annual meeting of shareholders (the “Annual Meeting”), the shareholders of Healthcare Triangle, Inc. (the “Company”): (i) elected four (4) directors to serve a one (1) year term; and (ii) ratified the appointment SRCO Professional Corporation, Chartered Professional Accountants (“SRCO”) as the Company’s independent registered public accounting firm for the year ending December 31, 2025.

The proposals presented at the Annual Meeting are described in more detail in the Company’s Definitive Proxy Statement on Schedule 14A (“Proxy Statement”) that was filed with the Securities and Exchange Commission on October 15, 2025. Holders of 21,423,722 shares of the Company’s common stock (and equivalent), or approximately 82.80% of the 25,873,304 shares of common stock (and equivalent) that were issued and outstanding and entitled to vote, were present virtually or represented by proxy at the Annual Meeting. The shares entitled to vote include the common stock of the Company and the Company’s Series A Super Voting Preferred Stock.

The following are the final voting results on the proposals presented to the Company’s shareholders at the Annual Meeting.

Proposal No. 1: Election of Directors

The Company’s shareholders elected all of the director nominees nominated by the Board to serve for a one-year term, until the 2026 annual meeting of shareholders and until their successors are duly elected and qualified. The table below sets forth the voting results for Proposal 1:

Director		Term Expires		For				Withheld				Broker Non-Votes
Sujatha Ramesh		2026			20,253,344				7,524				1,162,854
Dave Rosa		2026			20,171,021				89,847				1,162,854
Jainal Bhuiyan		2026			20,244,585				16,283				1,162,854
Ron McClurg		2026			20,250,055				10,813				1,162,854

Proposal No. 2: Ratification of the Auditors

The Company’s shareholders approved the resolution to approve SRCO as the Company’s independent public accounting firm for fiscal 2025. The table below sets forth the voting results for Proposal 2:

For		Against				Abstain				Broker Non-Votes
21,275,588			57,036				91,098				0

1

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

	Healthcare Triangle, Inc.
Dated: November 10, 2025	By:	/s/ David Ayanoglou
		David Ayanoglou
		Chief Financial Officer

2

FAQ

When was HCTI's 2025 annual meeting held?

The annual meeting was held on November 7, 2025.

How many HCTI shares were represented at the meeting?

21,423,722 shares were present or represented, approximately 82.80% of the 25,873,304 shares entitled to vote.

Which HCTI directors were elected in 2025 and with how many votes?

Elected for one-year terms: Sujatha Ramesh (For 20,253,344), Dave Rosa (For 20,171,021), Jainal Bhuiyan (For 20,244,585), Ron McClurg (For 20,250,055).

What were the auditor ratification results for HCTI?

Shareholders ratified SRCO as auditor: For 21,275,588, Against 57,036, Abstain 91,098, with 0 broker non-votes.

Were there broker non-votes on HCTI proposals?

Yes. Director elections recorded 1,162,854 broker non-votes each; the auditor ratification had 0 broker non-votes.

How long are the newly elected HCTI directors' terms?

Each director will serve a one-year term, expiring at the 2026 annual meeting and until successors are elected and qualified.